Skip to main content
Back to Investments

Vemedia

Status
Realised
Country
Netherlands
Strategy
Mid Cap
Sector
Entry
Dec-12
Exit
Oct-16
Fund
IK 2007

Fast growing producer of leading self-medication brands

Vemedia (“the Company”) developed, produced and sold owned, branded OTC (Over-The-Counter) pharmaceuticals in selected European countries.

At the time of exiting, Vemedia was the market leader in calming and sleeping self-medication in Europe with strong market positions in the Netherlands, Portugal, Italy and Spain with its Valdispert and Sleepzz brands. In addition, the Company had strong positions with the Excilor brand in medicated footcare. With headquarters in Diemen, the Netherlands, Vemedia was the largest self-medication company in the Netherlands, in part through its vitamin brands Dagravit, Roter and Optimax.

Vemidia was acquired in December 2012 by the IK 2007 Fund. It was later sold in October 2016 to an entity owned by Charterhouse Capital Partners LLP and which also owns La Coopération Pharmaceutique.

Our Value Creation Strategy

During our ownership, we worked alongside the management team to:

  • Increase organic growth through new product development;
  • Further expansion into selected European countries; and
  • Execute a focused consolidation strategy in the fragmented OTC market.

Investment Team

Frederik Jacobs

Director
Amsterdam